SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-008053
Filing Date
2013-02-06
Accepted
2013-02-06 17:07:03
Documents
3
Period of Report
2013-01-31
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-4595_18k.htm 8-K 26947
2 EX-3.1 a13-4595_1ex3d1.htm EX-3.1 74477
3 EX-3.2 a13-4595_1ex3d2.htm EX-3.2 119568
  Complete submission text file 0001104659-13-008053.txt   222111
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE NEW YORK NY 10022 212-831-1111
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 13578650
SIC: 2834 Pharmaceutical Preparations